![]()
|
Report Date : |
25.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
NAVANA PHARMACEUTICALS LIMITED |
|
|
|
|
Registered Office : |
Islam Chamber (8th Floor), 125/A Motijheel Commercial Area, Dhaka |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Date of Incorporation : |
31.03.1986 |
|
|
|
|
Com. Reg. No.: |
C-15428 |
|
|
|
|
Legal Form : |
Private Limited |
|
|
|
|
Line of Business : |
Manufacturing, Selling & Exporting of Pharmaceutical
products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 27,000.00 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Bangladesh |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Name |
Navana
Pharmaceuticals Limited |
|
Address |
Islam
Chamber (8th Floor), 125/A Motijheel Commercial Area, Dhaka |
|
Country |
Bangladesh |
|
Telephone No |
880-2-9557410, 9562714,
7160411 |
|
Fax No |
880-2-9569113 |
|
E-Mail |
|
|
Website |
|
|
Established |
March 1986 |
|
Commercial
Production From |
April 1992 |
|
Company Registration No |
C-15428 |
|
Registration date |
31 March 1986 |
|
Legal Status |
Private Limited |
|
Issuing Authority |
The
Registrar of Joint Stock Companies & Firms, Dhaka |
|
Business Type |
Manufacturing,
Selling & Exporting |
|
Status |
Satisfactory |
|
Payment Behavior |
No complaints have been heard regarding payments from
local suppliers or banks. |
|
Head Office |
3/C Purana Paltan,
Dhaka-1000, Bangladesh |
|
Telephone No |
880-2-9557410, 9562714,
7160411 |
|
Fax No |
880-2-9569113 |
|
E-Mail |
|
|
Website |
|
|
Corporate Office |
Islam Chamber (8th
Floor), 125/A Motijheel Commercial Area, Dhaka |
|
Factory |
Rupshi, Rupgonj,
Narayangonj Bangladesh |
|
Factory Telephone No |
NIL |
|
Factory Fax No |
NIL |
|
Warehouse |
Rupshi, Rupgonj,
Narayangonj Bangladesh |
|
Name |
Mr. Manzurul Islam |
|
Designation |
Chairman |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Nadeem A. Chaudhury |
|
Designation |
Managing
Director |
|
Nationality |
Bangladeshi |
|
Name |
Mr. Manzurul Islam |
|
Share Percent |
50% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. Nadeem A. Chaudhury |
|
Share Percent |
50% |
|
Nationality |
Bangladeshi |
|
Line of Business |
Manufacturing,
Selling & Exporting |
|
Items Dealing In |
Pharmaceutical
products |
|
Terms of Purchase |
Local: Cash or Credit Import: Against L/C |
|
Terms of
Purchase |
Local: Cash or Credit Export: Against L/C |
|
Name |
IFIC Bank Ltd |
|
Branch |
Motijheel Branch |
|
Address |
125/A Motijheel C/A, Dhaka-1000 |
|
SWIFT |
N/A |
|
|
|
|
Name |
Standard
Chartered Bank |
|
Branch |
Paltan Branch |
|
Address |
Puarana Paltan, Dhaka-1000 |
|
SWIFT |
N/A |
|
Year |
2010 |
2009 |
2008 |
|
Investment |
Tk.55 million |
Tk.53 million |
Tk.53 million |
|
Turnover |
Tk.487 million |
Tk.485.7 million |
Tk.485 million |
|
Liability |
Tk.11.8 million |
Tk.13.5 million |
Tk.14 million |
|
Assets |
Tk.73 million |
Tk.70 million |
Tk.70 million |
|
Authorized
Capital |
Tk.30 million |
|
Paid Up Capital |
Tk.3 million |
|
Each Share Value |
Tk.100.00 |
|
Currency |
Unit |
Bangladeshi Taka (BDT) |
|
Great Britain Pound |
1 |
121.2861 |
|
U.S Dollar |
1 |
75.9700 |
|
European Euro |
1 |
105.5983 |
|
Dishonored
Checks |
No Found |
|
Debt |
No Records Found |
|
Litigation |
No Records Found |
|
Performance
Defaults |
No Records Found |
|
Adverse Press
Coverage |
No Records Found |
|
Money Laundering |
No Records Found |
|
Amount |
Based On |
|
US$ 27,000.00 |
90 days |
|
Employees |
1,300 |
|
Office Area (Sq.
Ft) |
2,300 sq.ft (owned) |
|
Factory Area
(Sq. Ft) |
32,000 sq.ft (owned) |
|
Warehouse Area
(Sq. Ft) |
4,500 sq.ft (owned) |
|
Range of
Products |
Pharmaceutical
Products: 4
Analgesic & Anti-inflammatory 4
Analgesic & Antipyretic 4
Anthelmintic 4
Antiasthmatic 4 Antibiotic 4
Anticoccidial 4
Antidepressant 4
Antidiabetic 4
Antiemetic 4
Antiflatulent 4
Antifungal 4
Antihistamine 4
Antimigraine 4
Antiprotozoal 4
Antipsychotic 4
Antispasmodic 4
Antiulcerant 4
Antivertigo 4
Anxiolytic 4
Cardiovascular 4
Expectorant 4 Gastroprokinetic 4
Laxative 4 Opioid
Antagonist 4 Vitamin
& Mineral Animal
Health Division: 4
Anthelmintic 4
Antibiotic 4
Electrolyte / Saline 4 Feed
Additive 4 Feed
Grade Premix 4 Toxin
Binder 4
Vitamins, Minerals & Amino Acids |
|
Major
Clients |
4 Local
Medical 4 Local
Specialized Hospitals 4 Local
Consumer |
|
Export Market |
4 Southeast Asia |
|
Certifications |
4 ISO-9001:2000 |
|
Group Name |
4 Islam Group |
|
Subsidiaries /
Affiliates |
4 Bengal
Development Corporation Limited 4 Eastern
Housing Limited 4 Navana Health
Care Limited. 4 Aftab Bahumukhi Farms Limited 4 Aftab Hatchery Limited 4 Aftab
IT Limited |
|
Member |
4
Bangladesh Association of Pharmaceuticals, Dhaka 4 Dhaka Chamber of Commerce &
Industries, Dhaka |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.87 |
|
|
1 |
Rs.79.73 |
|
Euro |
1 |
Rs.69.53 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.